FibroGen Inc • FGEN

Capital at risk.

About FibroGen Inc
Ticker
info
FGEN
Trading on
info
NASDAQ
ISIN
info
US31572Q8087
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Thane Wettig
Headquarters
info
350 Bay Street, San Francisco, CA, United States, 94133
Employees
info
225
Website
info
fibrogen.com
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. Its pipeline products include FG-3165 and FG-3175, an anti-GAL-9 antibody for treatment of solid tumors. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Metrics
BasicAdvanced
Market cap
info
$39.3M
P/E ratio
info
-
EPS
info
-$12.85
Dividend Yield
info
0.00%
Beta
info
0.77
Forward P/E ratio
info
61.35
EBIDTA
info
$-58.1M
Ex dividend date
info
-
Price & volume
Market cap
info
$39.3M
Average daily volume
info
-
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
61.35
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
4.73
Price to book
info
53.83
Earnings
EPS
info
-$12.85
EPS estimate (current quarter)
info
-$4.01
EPS estimate (next quarter)
info
-$4.17
EBITDA
info
$-58.1M
Revenues (TTM)
info
$8.3M
Revenues per share (TTM)
info
$2.05
Technicals
Beta
info
0.77
52-week High
info
$12.60
52-week Low
info
$4.85
50-day moving average
info
$8.82
200-day moving average
info
$8.92
Short ratio
info
3.2
Short %
info
3.31%
Management effectiveness
ROE (TTM)
info
-1,015.79%
ROA (TTM)
info
-18.42%
Profit margin
info
2,598.87%
Gross profit margin
info
$-30.4M
Operating margin
info
-499.07%
Growth
Quarterly earnings growth (YoY)
info
53.60%
Quarterly revenue growth (YoY)
info
774.80%
Share stats
Outstanding Shares
info
4M
Float
info
3.6M
Insiders %
info
1.66%
Institutions %
info
28.01%
Analyst Insights & forecasts
info

50% Buy

50% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$43.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.08
-$0.20
60.00%
Q4 • 24Beat
$0.05
$0.02
150.00%
Q1 • 25Beat
-$3.39
-$0.09
-3,666.67%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.3M
$-7.6M
-564.02%
Q2 • 25
$1.1M
$201M
18,646.47%
Q3 • 25
-20.18%
-2,738.91%
-3,405.99%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$178M
$359M
201.67%
Q2 • 25
$137M
$120M
87.24%
Q3 • 25
-23.05%
-66.71%
-56.74%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$12.7M
$-0M
$-0M
$12.7M
Q2 • 25
$-1.8M
$87.2M
$-85.9M
$-1.9M
Q3 • 25
-114.56%
-670,561.54%
954,533.33%
-114.65%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a FibroGen Inc share?
Collapse

FibroGen Inc shares are currently traded for undefined per share.

How many shares does FibroGen Inc have?
Collapse

FibroGen Inc currently has 4M shares.

Does FibroGen Inc pay dividends?
Collapse

No, FibroGen Inc doesn't pay dividends.

What is FibroGen Inc 52 week high?
Collapse

FibroGen Inc 52 week high is $12.60.

What is FibroGen Inc 52 week low?
Collapse

FibroGen Inc 52 week low is $4.85.

What is the 200-day moving average of FibroGen Inc?
Collapse

FibroGen Inc 200-day moving average is $8.92.

Who is FibroGen Inc CEO?
Collapse

The CEO of FibroGen Inc is Thane Wettig.

How many employees FibroGen Inc has?
Collapse

FibroGen Inc has 225 employees.

What is the market cap of FibroGen Inc?
Collapse

The market cap of FibroGen Inc is $39.3M.

What is the P/E of FibroGen Inc?
Collapse

The current P/E of FibroGen Inc is null.

What is the EPS of FibroGen Inc?
Collapse

The EPS of FibroGen Inc is -$12.85.

What is the PEG Ratio of FibroGen Inc?
Collapse

The PEG Ratio of FibroGen Inc is 0.

What do analysts say about FibroGen Inc?
Collapse

According to the analysts FibroGen Inc is considered a buy.